Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 8;1(4):416-435.
doi: 10.34197/ats-scholar.2020-0016RE.

ATS Core Curriculum 2020. Adult Pulmonary Medicine

Colleen L Channick  1 , Garth Garrison  2 , Tristan J Huie  3 , Erin Narewski  4 , Caralee Caplan-Shaw  5 , Josalyn Cho  6 , Samaan Rafeq  5 , Raed Alalawi  7 , Rami Alashram  4 , Kristina L Bailey  8 , Eva M Carmona  9 , Naomi Habib  7 , Rebecca Kapolka  10 , Amita Krishnan  11 , Matthew R Lammi  11 , Tyler Peck  12 , Kelly M Pennington  9 , Parth Rali  4 , Bronwyn L Small  8 , Colin Swenson  10 , Alison Witkin  12 , Margaret M Hayes  13
Affiliations

ATS Core Curriculum 2020. Adult Pulmonary Medicine

Colleen L Channick et al. ATS Sch. .

Abstract

The American Thoracic Society Core Curriculum updates clinicians annually in adult and pediatric pulmonary disease, medical critical care, and sleep medicine in a 3- to 4-year recurring cycle of topics. The topics of the 2020 Pulmonary Core Curriculum include pulmonary vascular disease (submassive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension) and pulmonary infections (community-acquired pneumonia, pulmonary nontuberculous mycobacteria, opportunistic infections in immunocompromised hosts, and coronavirus disease [COVID-19]).

Keywords: COVID-19; community-acquired pneumonia; nontuberculous mycobacteria; pulmonary hypertension; submassive pulmonary embolism.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Chest computed tomographic image of the nodular–bronchiectatic phenotype of nontuberculous mycobacterial pulmonary disease showing centrilobular pulmonary nodules, tree-in-bud opacities, and cylindrical bronchiectasis.
Figure 2.
Figure 2.
Chest computed tomographic image of the fibrocavitary disease phenotype of nontuberculous mycobacterial pulmonary disease with an upper-lobe thick-walled cavitary lesion.
Figure 3.
Figure 3.
Aspergillus tracheobronchitis. A 78-year-old man receiving chemotherapy for diffuse large B-cell lymphoma was found to have diffuse mucosal plaques and ulcerations on bronchoscopy. Bronchial washings grew A. fumigatus.
Figure 4.
Figure 4.
Invasive pulmonary aspergillosis. (A) A 58-year-old woman on high-dose inhaled corticosteroids presented with an incidentally discovered left upper-lobe cavitary nodule on chest computed tomography (CT). (B) CT-guided biopsy of the nodule revealed acute branching and septate hyphae consistent with Aspergillus species.
Figure 5.
Figure 5.
Cryptococcus neoformans pulmonary infection. A 66-year-old man with pulmonary sarcoidosis on high-dose prednisone presented with fever, altered mental status, and progressive cough. A computed tomographic scan of the chest revealed bilateral peri-hilar and nodular opacities consistent with sarcoidosis. Serum and cerebrospinal-fluid cryptococcal antigens were positive.
Figure 6.
Figure 6.
Pneumocystis jirovecii pneumonia. A 41-year-old man with a history of kidney and pancreas transplant 3 years prior presented with progressive hypoxemic respiratory failure and diffuse bilateral ground-glass opacities on chest computed tomographic images. Serum β-1,3-d-glucan was greater than 10 times the upper limit of normal. Sputum P. jirovecii pneumonia polymerase chain reaction was positive.
Figure 7.
Figure 7.
Chest computed tomographic image showing pattern of bilateral patchy peripheral infiltrates in patient with coronavirus disease (COVID-19) infection.
Figure 8.
Figure 8.
Chest computed tomographic image showing pattern of bilateral ground-glass opacities in patient with coronavirus disease (COVID-19) infection.
See this image and copyright information in PMC

References

    1. Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence. A scientific statement from the American Heart Association. Circulation. 2019;140:e774–e801. - PubMed
    1. Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2019;40:3453–3455. - PubMed
    1. Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123:1788–1830. - PubMed
    1. Rali PM, Criner GJ. Submassive pulmonary embolism. Am J Respir Crit Care Med. 2018;198:588–598. - PubMed
    1. Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49:1601792. - PubMed

LinkOut - more resources